Literature DB >> 15090974

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.

R Phillip Dellinger, Jean M Carlet, Henry Masur, Herwig Gerlach, Thierry Calandra, Jonathan Cohen, Juan Gea-Banacloche, Didier Keh, John C Marshall, Margaret M Parker, Graham Ramsay, Janice L Zimmerman, Jean-Louis Vincent, Mitchell M Levy.   

Abstract

OBJECTIVE: In 2003, critical care and infectious disease experts representing 11 international organizations developed management guidelines for severe sepsis and septic shock that would be of practical use for the bedside clinician, under the auspices of the Surviving Sepsis Campaign, an international effort to increase awareness and improve outcome in severe sepsis.
DESIGN: The process included a modified Delphi method, a consensus conference, several subsequent smaller meetings of subgroups and key individuals, teleconferences, and electronic-based discussion among subgroups and among the entire committee.
METHODS: We used a modified Delphi methodology for grading recommendations, built on a 2001 publication sponsored by the International Sepsis Forum. We undertook a systematic review of the literature graded along five levels to create recommendation grades from A to E, with A being the highest grade. Pediatric considerations were provided to contrast adult and pediatric management.
RESULTS: Key recommendations, listed by category and not by hierarchy, include early goal-directed resuscitation of the septic patient during the first 6 hrs after recognition; appropriate diagnostic studies to ascertain causative organisms before starting antibiotics; early administration of broad-spectrum antibiotic therapy; reassessment of antibiotic therapy with microbiology and clinical data to narrow coverage, when appropriate; a usual 7-10 days of antibiotic therapy guided by clinical response; source control with attention to the method that balances risks and benefits; equivalence of crystalloid and colloid resuscitation; aggressive fluid challenge to restore mean circulating filling pressure; vasopressor preference for norepinephrine and dopamine; cautious use of vasopressin pending further studies; avoiding low-dose dopamine administration for renal protection; consideration of dobutamine inotropic therapy in some clinical situations; avoidance of supranormal oxygen delivery as a goal of therapy; stress-dose steroid therapy for septic shock; use of recombinant activated protein C in patients with severe sepsis and high risk for death; with resolution of tissue hypoperfusion and in the absence of coronary artery disease or acute hemorrhage, targeting a hemoglobin of 7-9 g/dL; appropriate use of fresh frozen plasma and platelets; a low tidal volume and limitation of inspiratory plateau pressure strategy for acute lung injury and acute respiratory distress syndrome; application of a minimal amount of positive end-expiratory pressure in acute lung injury/acute respiratory distress syndrome; a semirecumbent bed position unless contraindicated; protocols for weaning and sedation/analgesia, using either intermittent bolus sedation or continuous infusion sedation with daily interruptions/lightening; avoidance of neuromuscular blockers, if at all possible; maintenance of blood glucose <150 mg/dL after initial stabilization; equivalence of continuous veno-veno hemofiltration and intermittent hemodialysis; lack of utility of bicarbonate use for pH > or =7.15; use of deep vein thrombosis/stress ulcer prophylaxis; and consideration of limitation of support where appropriate. Pediatric considerations included a more likely need for intubation due to low functional residual capacity; more difficult intravenous access; fluid resuscitation based on weight with 40-60 mL/kg or higher needed; decreased cardiac output and increased systemic vascular resistance as the most common hemodynamic profile; greater use of physical examination therapeutic end points; unsettled issue of high-dose steroids for therapy of septic shock; and greater risk of hypoglycemia with aggressive glucose control.
CONCLUSION: Evidence-based recommendations can be made regarding many aspects of the acute management of sepsis and septic shock that are hoped to translate into improved outcomes for the critically ill patient. The impact of these guidelines will be formally tested and guidelines updated annually and even more rapidly as some important new knowledge becomes as available.

Entities:  

Mesh:

Year:  2004        PMID: 15090974     DOI: 10.1097/01.ccm.0000117317.18092.e4

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  622 in total

Review 1.  Year in review 2010: Critical Care--Multiple organ dysfunction and sepsis.

Authors:  Etienne de Montmollin; Djillali Annane
Journal:  Crit Care       Date:  2011-12-05       Impact factor: 9.097

2.  Comment on "Surviving sepsis campaign guidelines for the management of severe sepsis and septic shock" by Dellinger et al.

Authors:  D F Zandstra; P H J van der Voort
Journal:  Intensive Care Med       Date:  2004-07-23       Impact factor: 17.440

3.  Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria.

Authors:  Peter M C Klein Klouwenberg; David S Y Ong; Marc J M Bonten; Olaf L Cremer
Journal:  Intensive Care Med       Date:  2012-04-05       Impact factor: 17.440

4.  Recurrent fever and bacteraemia after endoscopic variceal haemostasis with cyanoacrylate: a case report.

Authors:  P A Reuken; T Bruns; B Zimmer; A Michael; F M Brunkhorst; M W Pletz; A Stallmach
Journal:  Infection       Date:  2011-10-15       Impact factor: 3.553

5.  Merinoff symposium 2010: sepsis--an international call to action.

Authors:  Christopher J Czura
Journal:  Mol Med       Date:  2010 May-Jun       Impact factor: 6.354

Review 6.  [Results of studies in critical care medicine in the year 2009 : update].

Authors:  M Bernhard; G Marx; K Weismüller; C Lichtenstern; K Mayer; F M Brunkhorst; M A Weigand
Journal:  Anaesthesist       Date:  2010-05       Impact factor: 1.041

7.  Older Sepsis Survivors Suffer Persistent Disability Burden and Poor Long-Term Survival.

Authors:  Robert T Mankowski; Stephen D Anton; Gabriela L Ghita; Babette Brumback; Michael C Cox; Alicia M Mohr; Christiaan Leeuwenburgh; Lyle L Moldawer; Philip A Efron; Scott C Brakenridge; Frederick A Moore
Journal:  J Am Geriatr Soc       Date:  2020-04-15       Impact factor: 5.562

8.  Risk of death does not alter the efficacy of hydrocortisone therapy in a mouse E. coli pneumonia model: risk and corticosteroids in sepsis.

Authors:  Yan Li; Xizhong Cui; Xuemei Li; Steven B Solomon; Robert L Danner; Steven M Banks; Yvonne Fitz; Djillali Annane; Charles Natanson; Peter Q Eichacker
Journal:  Intensive Care Med       Date:  2007-11-09       Impact factor: 17.440

9.  Pilot study on the influence of liver blood flow and cardiac output on the clearance of propofol in critically ill patients.

Authors:  Mariska Y M Peeters; Leon P H J Aarts; Ferenc A Boom; Leo J Bras; Dick Tibboel; Meindert Danhof; Catherijne A J Knibbe
Journal:  Eur J Clin Pharmacol       Date:  2007-11-13       Impact factor: 2.953

10.  Removal of inflammatory ascites is associated with dynamic modification of local and systemic inflammation along with prevention of acute lung injury: in vivo and in silico studies.

Authors:  Bryanna Emr; David Sadowsky; Nabil Azhar; Louis A Gatto; Gary An; Gary F Nieman; Yoram Vodovotz
Journal:  Shock       Date:  2014-04       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.